Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06866535
Recruiting Observational

VIP - Vascular Infection Project

NCT06866535 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Bordeaux
Phase
Observational
Started
2022-05-10
Last updated
2025-03-10

Condition(s) studied

AortitisVascular Graft InfectionBlood Vessel ProsthesisInfections

Study summary

Constitution of a prospective multicentric observational database to study vascular infections, both native, especially aortitis, and vascular graft and endograft infections. Clinical and paraclinical data on medical, surgical, anesthetic and intensive care management will be collected in order to better characterize these infections

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ≥ 18 years-old; * all patients with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent), * oral consent Exclusion Criteria: * patient under legal protection

Primary outcome measure(s)

  • mortality — Year 1
    mortality r

Trial sites (1)

FacilityCityRegionStatus
CHU Bordeaux Bordeaux France Recruiting

More University Hospital, Bordeaux trials in France

Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN) Recruiting
A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression Recruiting
Parkinsonism-Related Oscillations in the Cortico-Basal Ganglia-Thalamic Network During Movement: Beyond the Frequency Range Recruiting
Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction Recruiting
Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules Recruiting

Other trials for the same condition

X-linked Moesin Associated Immunodeficiency Recruiting
Description of the Immune Response to Yellow Fever Vaccination Recruiting
TocILizumab in aorTitis in GCA (TILT) Recruiting
Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06866535 on ClinicalTrials.gov ↗ ← All trials in France